Who we are
We are a highly innovative Canadian life-sciences company focused on the research, development, manufacturing, sales and distribution of innovative, novel, branded and generic ophthalmic drugs and ophthalmic OTC products.
Genix Pharmaceuticals Corporation is especially committed to providing these safe, high quality and highly effective, evidence-based, ophthalmic drugs and OTC products to patients and consumers in Canada and globally, to safely and effectively treat and prevent their eye health issues and diseases.
In 2018 generics were used to fill 90% of all prescriptions in the United States. If the use of generic medicines in Canada were equal to the US levels, Canadians would have saved more than $11 billion in 2018
-Canadian Generics Pharmaceutical Association
How we come to success
P.Pharm, BSc., CEO, Director
Sina has over 18 years of pharmaceuticals and pharmacy management experience and is actively engaged in the sales, marketing and export of pharmaceuticals, OTC drugs and health supplements to the U.S. and Middle East. He is the principal of Coal Harbour Compounding Pharmacy and President of SP RX Services and formerly a partner of one of the largest independent pharmacy chain – Pure Integrative Pharmacies of British Colombia.
Danny Lee CPA, CA
Mr. Lee is a Chartered Professional Accountant (CPA, CA) with more than 20 years of experience working with public companies in mineral exploration, software, technology and distribution. Mr. Lee's experience includes financial reporting for both Canadian and US listed companies with international operations, corporate finance, strategic planning, tax planning, corporate governance, equity financings and due diligence for acquisitions. Mr. Lee has a Bachelor of Commerce degree from the University of British Columbia
Mr. Yea is currently president of Investco Capital Management Inc., a private Vancouver-based company that invests in a diverse range of businesses and projects. He was formerly chairman, president, and CEO of TSX-listed Datawest Solutions Inc., a banking technology and payment processing company, and president and CEO of a publicly listed national financial services organization. Mr. Yea was a former MOB of governors of the Vancouver Stock Exchange, and chaired several of its committees. Formerly a member of the faculty advisory board of the Sauder School of Business at UBC, Mr. Yea also served on the boards of several other public companies including chairing special board committees that oversaw privatizations and divestitures. Most recently he served as chairman and lead director of Apteryx Imaging Inc. (TSXV: XRAY) which was acquired in an all cash transaction in August 2020 by a US private equity firm. He holds a Bachelor of Commerce degree from UBC in both Urban Land Economics and Finance, and was a member of the Real Estate Institute of B.C. and of the Institute of Certified Management Consultants of B.C.
MBA, CPA, LLB, CFO, Director
Jamie over 20 years experience in accounting and finance for private and public companies ranging from brokerage and investment through to manufacturing, distribution, resources, pharmaceuticals and service. He has acted in several roles including CFO, Finance Manager and Controller for several domestic and international companies. He was previously CFO for TSX-V listed Vanc Pharmaceuticals Inc. and has had significant experience with managing the financial requirements of a fully fledged prescription drugs pharmaceuticals company.
Kevin is an accomplished professional with more than 15 years working in with Canadian publicly traded companies. He has successfully closed over $100 Million in capital funding and has developed an extensive network of funding partners throughout North America and Europe. Kevin has served in many senior roles including directorship and executive management roles and assisted in the launch of several publicly listed companies.
ACQUIRED OPHTHALMIC DRUGS
Our network of advisors
Dr. Erik Vu, Executive Advisor
Dr. Vu is an Emergency and Critical Care Physician for Vancouver Coastal Health Authority, and a Clinical Assistant Professor in the Departments of Emergency and Critical Care Medicine at the University of British Columbia, where he also completed Fellowship training in Emergency Medical Services and Critical Care Transport. Concurrent with his sub-specialty training, Dr. Vu has special interest in Special Operations Medicine, including CBRNE Disaster and Tactical Medicine. Dr. Vu has completed postgraduate studies in Aviation Medicine and has qualified as a Flight Surgeon with the Department of National Defense, as part of his portfolio in both private and public sectors of Aeromedical Evacuation.
Dawn Polley, Executive Advisor
Ms. Polley, a Pharmacist and Businesswoman is President and CEO of the Granville Business Group.This multi-faceted company includes healthcare and pharmacy practise consulting; an on-line Canadian pharmacy and a business solution based company serving various industries. Her experience spans more than 40 years. She has owned her own retail pharmacies as well as managed pharmacy operations and professional services for 80 Shoppers Drug Mart stores in BC.Ms. Polley has served on many professional boards and committees. Considered a leader and an expert in her Industry Ms.Polley has made many presentations to Canadian and US Senate hearings and has spoken at a number of public forums in Washington.
Through the years